CHARLES F GROSE, MD
Medical Practice at Hawkins Dr, Iowa City, IA
License number
Iowa 24603
Category
Medical Practice
Type
Pediatric Infectious Diseases
Address
Address
200 Hawkins Dr, Iowa City, IA 52242
Phone
(319) 356-2270
(319) 356-4855 (Fax)
(319) 356-4855 (Fax)
Professional information
Dr. Charles F Grose, Iowa City IA - MD (Doctor of Medicine)
Specialties:
Pediatric Infectious Disease Medicine
Address:
UNIVERSITY OF IOWA HOSPITAL
200 Hawkins Dr, Iowa City 52242
(319) 356-8486 (Phone)
200 Hawkins Dr, Iowa City 52242
(319) 356-8486 (Phone)
Certifications:
Pediatric Infectious Disease Medicine, 2002, Pediatrics, 1973
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
UNIVERSITY OF IOWA HOSPITAL
200 Hawkins Dr, Iowa City 52242
University of Iowa Hospital and Clinics
200 Hawkins Dr, Iowa City 52242
200 Hawkins Dr, Iowa City 52242
University of Iowa Hospital and Clinics
200 Hawkins Dr, Iowa City 52242
Education:
Medical School
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1967
Albert Einstein Coll Med
Einstein
University of California-San Francisco
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1967
Albert Einstein Coll Med
Einstein
University of California-San Francisco
Variant Varicella-Zoster Viruses And Methods Of Use
US Patent:
6528066, Mar 4, 2003
Filed:
Sep 14, 2000
Appl. No.:
09/661596
Inventors:
Charles F. Grose - Iowa City IA
Richard Santos - Iowa City IA
Richard Santos - Iowa City IA
Assignee:
University of Iowa Research Foundation - Iowa City IA
International Classification:
A61K 39245
US Classification:
4242291, 4242301, 4242041, 435 911, 435 9133, 435 89, 536 2372
Abstract:
The present invention provides methods directed to detecting antibodies that specifically bind to a varicella zoster polypeptide, detecting the presence of a varicella zoster virus in an animal, diagnosing a disease caused by varicella zoster virus, and detecting a varicella zoster virus having a single nucleotide polymorphism in ORF68. The present invention also provides a vaccine composition, a method for producing a modified attenuated varicella zoster virus, isolated polynucleotides, and isolated polypeptides, and viruses.
Peptide Tag For Immunodetection And Immunopurification
US Patent:
6255462, Jul 3, 2001
Filed:
Sep 29, 1997
Appl. No.:
8/939323
Inventors:
Charles F. Grose - Iowa City IA
Assignee:
University of Iowa Research Foundation - Iowa City IA
International Classification:
C07K 100
US Classification:
530413
Abstract:
This invention discloses the incorporation of a peptide QRQYGDVFKGD (SEQ ID NO:1) from glycoprotein gE of Varicella zoster virus into a protein or polypeptide sequence for immunoisolation, immunopurification and immunodetection.
Peptide Tag For Immunodetection And Immunopurification
US Patent:
5710248, Jan 20, 1998
Filed:
Jul 29, 1996
Appl. No.:
8/681935
Inventors:
Charles F. Grose - Iowa City IA
Assignee:
University of Iowa Research Foundation - Iowa City IA
International Classification:
A61K 3804, C07K 100, C07K 500, G01N 3353
US Classification:
530327
Abstract:
This invention discloses the incorporation of a peptide QRQYGDVFKGD (SEQ ID NO:1) from glycoprotein gE of Varicella zoster virus into a protein or polypeptide sequence for immunoisolation, immunopurification and immunodetection.
Variant Varicella-Zoster Viruses And Methods Of Use
US Patent:
6843997, Jan 18, 2005
Filed:
Nov 6, 2002
Appl. No.:
10/288823
Inventors:
Charles F. Grose - Iowa City IA, US
Richard Santos - Saint Louis MO, US
Richard Santos - Saint Louis MO, US
Assignee:
University of Iowa Research Foundation - Iowa City IA
International Classification:
A51K 39245
US Classification:
4242301, 4242041, 4241301, 435 6, 435975, 435345
Abstract:
The present invention provides methods directed to detecting antibodies that specifically bind to a varicella zoster polypeptide, detecting the presence of a varicella zoster virus in an animal, diagnosing a disease caused by varicella zoster virus, and detecting a varicella zoster virus having a single nucleotide polymorphism in ORF68. The present invention also provides a vaccine composition, a method for producing a modified attenuated varicella zoster virus, isolated polynucleotides, and isolated polypeptides, and viruses.